Atlas Trials

A Treatment Study of Mucopolysaccharidosis Type IIIB

Clinical trial NCT02754076 · COMPLETED

Trial details

NCT number
NCT02754076
Sponsor
Allievex Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MPS III BMucopolysaccharidosis Type IIIB
Start date
2016-04-01
Primary completion
2020-06-24
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.